Association between IL-17, IL-23 with neurocognitive scales in patients with Alzheimer’s disease

Please use this identifier to cite or link to this item: https://essuir.sumdu.edu.ua/handle/123456789/87570

Or use following links to share this resource in social networks: Recommend this item

Title	Association between IL-17, IL-23 with neurocognitive scales in patients with Alzheimer’s disease
Authors	Mudrenko, Iryna Hryhorivna Chyniak, Olha Serhiivna
ORCID	http://orcid.org/0000-0002-1849-338X http://orcid.org/0000-0002-6008-1039
Keywords	Alzheimer’s disease inflammation interleukin neurocognitive scales
Type	Conference Papers
Date of Issue	2021
URI	https://essuir.sumdu.edu.ua/handle/123456789/87570
Publisher	Cambridge University Press
License	Creative Creative Commons Attribution-ShareAlike 4.0 International
Citation	Mudrenko, I., & Chyniak, O. (2021). Association between IL-17, IL-23 with neurocognitive scales in patients with Alzheimer’s disease. European Psychiatry, 64(S1), S718-S719. doi:10.1192/j.eurpsy.2021.1903
Abstract	Alzheimer’s disease (AD) is a degenerative brain disease and the most common cause of dementia. Evidence suggests that various cytokines, including interleukins (IL) IL-6, IL-10, IL-12 are actively involved in the pathogenesis of AD. The role of IL-17 and IL-23 is less clear.
Appears in Collections:	Наукові видання (НН МІ)